416 related articles for article (PubMed ID: 27251005)
1. MicroRNA in pancreatic cancer.
Yonemori K; Kurahara H; Maemura K; Natsugoe S
J Hum Genet; 2017 Jan; 62(1):33-40. PubMed ID: 27251005
[TBL] [Abstract][Full Text] [Related]
2. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.
Cheng RF; Wang J; Zhang JY; Sun L; Zhao YR; Qiu ZQ; Sun BC; Sun Y
Chin J Cancer; 2016 Jul; 35(1):64. PubMed ID: 27371108
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.
Quattrochi B; Gulvady A; Driscoll DR; Sano M; Klimstra DS; Turner CE; Lewis BC
Oncotarget; 2017 May; 8(22):35902-35918. PubMed ID: 28415794
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
Frampton AE; Castellano L; Colombo T; Giovannetti E; Krell J; Jacob J; Pellegrino L; Roca-Alonso L; Funel N; Gall TM; De Giorgio A; Pinho FG; Fulci V; Britton DJ; Ahmad R; Habib NA; Coombes RC; Harding V; Knösel T; Stebbing J; Jiao LR
Gastroenterology; 2014 Jan; 146(1):268-77.e18. PubMed ID: 24120476
[TBL] [Abstract][Full Text] [Related]
7. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
8. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Rajamani D; Bhasin MK
Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
[TBL] [Abstract][Full Text] [Related]
9. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma.
Liu PF; Jiang WH; Han YT; He LF; Zhang HL; Ren H
Genet Mol Res; 2015 Aug; 14(3):10288-97. PubMed ID: 26345967
[TBL] [Abstract][Full Text] [Related]
10. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW; Oien KA; McKay CJ; Jamieson NB
Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
[TBL] [Abstract][Full Text] [Related]
11. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma.
Sun L; Chua CYX; Tian W; Zhang Z; Chiao PJ; Zhang W
J Genet Genomics; 2015 Oct; 42(10):563-577. PubMed ID: 26554910
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
Felix TF; Lopez Lapa RM; de Carvalho M; Bertoni N; Tokar T; Oliveira RA; M Rodrigues MA; Hasimoto CN; Oliveira WK; Pelafsky L; Spadella CT; Llanos JC; F Silva G; Lam WL; Rogatto SR; Amorim LS; Drigo SA; Carvalho RF; Reis PP
PLoS One; 2019; 14(5):e0217421. PubMed ID: 31150430
[TBL] [Abstract][Full Text] [Related]
17. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma.
Sun H; Zhao L; Pan K; Zhang Z; Zhou M; Cao G
Oncol Rep; 2017 May; 37(5):2779-2786. PubMed ID: 28339085
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
20. High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.
Giovannetti E; van der Velde A; Funel N; Vasile E; Perrone V; Leon LG; De Lio N; Avan A; Caponi S; Pollina LE; Gallá V; Sudo H; Falcone A; Campani D; Boggi U; Peters GJ
PLoS One; 2012; 7(11):e49145. PubMed ID: 23155457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
